ArticleInternational neurourology journal2025
Deep Learning-Based Uroflowmetry Curve Analysis Improves the Noninvasive Diagnosis of Lower Urinary Tract Symptoms.
Article in International neurourology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Electrotherapy Plus Photobiostimulation for the Treatment of Mild Pelvic Organ Prolapse and Stress Urinary Incontinence.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThis study aimed to evaluate the performance of an artificial intelligence (AI)-based analysis of uroflowmetry (UFM) curve images, enhanced with customized preprocessing techniques, to improve diagnostic accuracy for bladder outlet obstruction (BOO) and detrusor underactivity (DUA).
methodsWe retrospectively analyzed 2,579 UFM curve images from patients who underwent urodynamic study (UDS), including 725 normal and 1,854 abnormal cases (736 BOO and 1,387 DUA). A VGG16 convolutional neural network model was developed to perform 3 binary classification tasks: normal versus abnormal, BOO versus non-BOO, and DUA versus non-DUA. To improve model performance, we implemented a preprocessing pipeline consisting of denoising, cropping, axis scaling, and color-coding of clinical parameters such as voided volume and postvoid residual volume (PVR). Model performance was evaluated using 5-fold stratified cross-validation and the area under the receiver operating characteristic curve (AUROC).
resultsAbnormal cases demonstrated a lower median maximum flow rate (8.9 mL/sec vs. 14.8 mL/sec), higher PVR (60.0 mL vs. 20.0 mL), and lower voiding efficiency (78.5% vs. 92.5%) than normal cases. Within the abnormal group, the BOO subgroup showed a higher PVR (80.0 mL) than the non-BOO subgroup (30.0 mL). After applying the preprocessing pipeline, model performance improved, with AUROC increasing from 0.807±0.024 to 0.827±0.016 for normal vs. abnormal classification, from 0.749±0.019 to 0.773±0.034 for BOO classification, and from 0.693±0.016 to 0.709±0.031 for DUA classification.
conclusionAI-based analysis of UFM curve images, enhanced through customized preprocessing, improved diagnostic accuracy in patients with lower urinary tract symptoms, effectively identifying BOO and DUA. This noninvasive method may serve as an adjunct or screening tool to reduce reliance on invasive UDS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.